Saturday, April 19, 2025

AIUM 2025: POCUS EDUCATIONAL POWER-DUO TAKES ON GLOBAL IMAGING & DIVERSITY

Dr. Ramos has been a global champion for Point of Care Ultrasound adoption across the continuum of care with a particular emphasis in primary care and global health.  Partnering with medical imaging heavyweight like Dr. Robert Bard at the 2025 AIUM Conference was a landmark experience for both educators. This "power-collab" stylishly combined their unique perspectives (from generations apart) to deliver a compelling chorus of a worldly showcase on "Advances in Portable Imaging & POCUS in the Evaluation of Breast and Liver Disease". 

Both leaders found many common views about ultrasound imaging- including the status of the current global state of health and the future of non-invasive diagnostics.  Since the early 70's, Dr. Bard paved his avenue with exploratory research, committing to the movement by collaborating with global colleagues.  He based a practice on pushing the boundaries of ultrasound in areas like cancer, chronic disorders and some of the most challenging pathologies.  Dr. Ramos, a family physician took point of care ultrasound onto the international stage (with the support of the W.H.O.) by bringing education and  access to POCUS in resource-limited settings throughout underserved areas of the world. Together, their mission to drive the ultrasound movement, its benefits to the community and its appeal to just about ANY economic platform rang louder than ever, with both crusaders on the mic. 

Courtesy of GUSI- Global Ultrasound Institute
"If this presentation was packaged for future events, it certainly brought new life to CME's and industry conferences everywhere", said Marilyn Abrahamson, editor of the upcoming BARD/RAMOS video series. "As a musician, I am reminded of every duet like Simon and Garfunkel or Tony Bennet and everyone else. Their differences in look, voice and vibe was so enjoyable that it relayed the absolute message of globalism and diversity in its most classic sense!" 



Brainstorming this unique presentation format was a process (itself) worth documenting.  "I have never been more impressed at the vision and energy that Mena (Ramos) had established from start to finish of the program", stated Dr. Bard. "From our first chat about 'a new kind of presentation',  we were completely taken by her vision to re-invent the format.  It sounded like so much fun and yet there was a powerful strategy to the harmony.  By having 2 speakers working the podium this way in a medical convention was completely unheard of... this idea of a reverse Q&A  (much like a multi-host talk show) was never part of the conference tradition of this size.  You couldn't have two speakers more synchronized and yet we touched into areas that were so vastly different... in the end, we covered great ground far better than any one speaker would care to attempt on a stage like this!"

Both doctors admitted that the AIUM presentation was a pilot for a much larger educational summit between them and other future speakers. Dr. Bard and his program director Dr. Lennard Gettz is underway mapping more duo-speakerships in 2025 including webinars and podcasts - pursuing that discussion-style energy that he first experienced at the AIUM conference with Dr. Ramos.


-------------------------------------------------------------------------------------------------------------------------


WHO IS DR. MENA RAMOS

Dr. Mena Ramos’ path into Point-of-Care Ultrasound (POCUS) was neither linear nor accidental. It emerged organically from her frontline experiences in medicine, both locally and globally, where she consistently saw the divide between medical potential and reality. From early on, she was captivated not just by the science of medicine but by its human element—how and where it reaches people, and more often, where it doesn’t.

A Vision for Equitable Healthcare Through Point-of-Care Ultrasound

Her first real introduction to POCUS occurred during her residency, where she witnessed its immediate utility in emergency care. “You could take one look and change the whole course of a diagnosis,” she once remarked. The precision, portability, and real-time nature of ultrasound opened her eyes to what she called “medicine in motion”—diagnosis and decision-making that meets the patient exactly where they are. But it wasn’t until she stepped into global health work that POCUS took on a far greater meaning.

While working in rural and underserved regions—across Latin America, sub-Saharan Africa, and Southeast Asia—Dr. Ramos encountered countless barriers to care. Imaging, often taken for granted in developed nations, was a rare luxury in these settings. Something as simple as diagnosing an ectopic pregnancy, a pleural effusion, or a gallbladder issue became life-threatening without the appropriate tools. For her, this wasn’t just a clinical gap—it was a systemic failure.

What struck her most profoundly was how POCUS could level the playing field. Unlike MRI or CT, ultrasound required no massive infrastructure, and with handheld devices becoming increasingly affordable and easy to use, the technology held promise for revolutionizing diagnostic care in low-resource settings. It was this potential—of democratizing access to accurate, fast, and safe imaging—that turned her professional interest into a mission.

Dr. Ramos became an active proponent of teaching POCUS as a skill, not just a tool. She emphasized the importance of building local capacity, rather than creating dependency on external aid. In the communities she served, she often ran hands-on workshops for local clinicians, nurses, and midwives—many of whom had never seen an ultrasound machine before. By training them directly, she empowered them to perform high-stakes assessments in real time, reducing diagnostic delays and unnecessary referrals.

Beyond the clinical benefits, she saw POCUS as a form of health equity. It closed the gap between urban hospitals and rural clinics. It allowed maternal care in villages without obstetricians. It supported trauma triage in conflict zones and disaster relief areas. In her view, ultrasound was more than technology—it was a translator, a bridge, a voice for patients whose symptoms might otherwise go unheard.

Her work has also involved collaborating with global health organizations and academic institutions to expand ultrasound training curricula. She has spoken on international panels and participated in multi-center research focused on improving ultrasound accessibility. Dr. Ramos continues to advocate for the integration of POCUS into primary care, emergency response, and even community health worker protocols—pushing for a broader redefinition of who gets to use advanced diagnostic tools.

In her current practice, Dr. Ramos blends clinical care with outreach, mentorship, and education. She champions interdisciplinary efforts to scale up training and encourages medical students to think beyond hospital walls. "POCUS reminds us that healthcare doesn't have to be centralized to be effective," she says. "It can—and should—travel to where it's needed most."

Dr. Ramos’s story is one of innovation rooted in empathy, and of science in service to equity. Through her work, she’s helping to shape a future where no patient is invisible due to their location, and where frontline care is empowered by information, not restricted by geography.

Friday, April 18, 2025

POCUS Tech Spotlight: Who is Dr. Mena Ramos?

Dr. Mena Ramos’ path into Point-of-Care Ultrasound (POCUS) was neither linear nor accidental. It emerged organically from her frontline experiences in medicine, both locally and globally, where she consistently saw the divide between medical potential and reality. From early on, she was captivated not just by the science of medicine but by its human element—how and where it reaches people, and more often, where it doesn’t.

A Vision for Equitable Healthcare Through Point-of-Care Ultrasound

Her first real introduction to POCUS occurred during her residency, where she witnessed its immediate utility in emergency care. “You could take one look and change the whole course of a diagnosis,” she once remarked. The precision, portability, and real-time nature of ultrasound opened her eyes to what she called “medicine in motion”—diagnosis and decision-making that meets the patient exactly where they are. But it wasn’t until she stepped into global health work that POCUS took on a far greater meaning.

While working in rural and underserved regions—across Latin America, sub-Saharan Africa, and Southeast Asia—Dr. Ramos encountered countless barriers to care. Imaging, often taken for granted in developed nations, was a rare luxury in these settings. Something as simple as diagnosing an ectopic pregnancy, a pleural effusion, or a gallbladder issue became life-threatening without the appropriate tools. For her, this wasn’t just a clinical gap—it was a systemic failure.

What struck her most profoundly was how POCUS could level the playing field. Unlike MRI or CT, ultrasound required no massive infrastructure, and with handheld devices becoming increasingly affordable and easy to use, the technology held promise for revolutionizing diagnostic care in low-resource settings. It was this potential—of democratizing access to accurate, fast, and safe imaging—that turned her professional interest into a mission.

Dr. Ramos became an active proponent of teaching POCUS as a skill, not just a tool. She emphasized the importance of building local capacity, rather than creating dependency on external aid. In the communities she served, she often ran hands-on workshops for local clinicians, nurses, and midwives—many of whom had never seen an ultrasound machine before. By training them directly, she empowered them to perform high-stakes assessments in real time, reducing diagnostic delays and unnecessary referrals.

Beyond the clinical benefits, she saw POCUS as a form of health equity. It closed the gap between urban hospitals and rural clinics. It allowed maternal care in villages without obstetricians. It supported trauma triage in conflict zones and disaster relief areas. In her view, ultrasound was more than technology—it was a translator, a bridge, a voice for patients whose symptoms might otherwise go unheard.

Her work has also involved collaborating with global health organizations and academic institutions to expand ultrasound training curricula. She has spoken on international panels and participated in multi-center research focused on improving ultrasound accessibility. Dr. Ramos continues to advocate for the integration of POCUS into primary care, emergency response, and even community health worker protocols—pushing for a broader redefinition of who gets to use advanced diagnostic tools.

In her current practice, Dr. Ramos blends clinical care with outreach, mentorship, and education. She champions interdisciplinary efforts to scale up training and encourages medical students to think beyond hospital walls. "POCUS reminds us that healthcare doesn't have to be centralized to be effective," she says. "It can—and should—travel to where it's needed most."

Dr. Ramos’s story is one of innovation rooted in empathy, and of science in service to equity. Through her work, she’s helping to shape a future where no patient is invisible due to their location, and where frontline care is empowered by information, not restricted by geography.

-------------------------------------------------------------------------------------------------------------------------

AIUM 2025: POCUS EDUCATIONAL POWER-DUO TAKES ON GLOBAL IMAGING & DIVERSITY

Dr. Ramos has been a global champion for Point of Care Ultrasound adoption across the continuum of care with a particular emphasis in primary care and global health.  Partnering with medical imaging heavyweight like Dr. Robert Bard at the 2025 AIUM Conference was a landmark experience for both educators. This "power-collab" stylishly combined their unique perspectives (from generations apart) to deliver a compelling chorus of a worldly showcase on "Advances in Portable Imaging & POCUS in the Evaluation of Breast and Liver Disease". 

Both leaders found many common views about ultrasound imaging- including the status of the current global state of health and the future of non-invasive diagnostics.  Since the early 70's, Dr. Bard paved his avenue with exploratory research, committing to the movement by collaborating with global colleagues.  He based a practice on pushing the boundaries of ultrasound in areas like cancer, chronic disorders and some of the most challenging pathologies.  Dr. Ramos, a family physician took point of care ultrasound onto the international stage (with the support of the W.H.O.) by bringing education and  access to POCUS in resource-limited settings throughout underserved areas of the world. Together, their mission to drive the ultrasound movement, its benefits to the community and its appeal to just about ANY economic platform rang louder than ever, with both crusaders on the mic. 

Courtesy of GUSI- Global Ultrasound Institute
"If this presentation was packaged for future events, it certainly brought new life to CME's and industry conferences everywhere", said Marilyn Abrahamson, editor of the upcoming BARD/RAMOS video series. "As a musician, I am reminded of every duet like Simon and Garfunkel or Tony Bennet and everyone else. Their differences in look, voice and vibe was so enjoyable that it relayed the absolute message of globalism and diversity in its most classic sense!" 

Brainstorming this unique presentation format was a process (itself) worth documenting.  "I have never been more impressed at the vision and energy that Mena (Ramos) had established from start to finish of the program", stated Dr. Bard. "From our first chat about 'a new kind of presentation',  we were completely taken by her vision to re-invent the format.  It sounded like so much fun and yet there was a powerful strategy to the harmony.  By having 2 speakers working the podium this way in a medical convention was completely unheard of... this idea of a reverse Q&A  (much like a multi-host talk show) was never part of the conference tradition of this size.  You couldn't have two speakers more synchronized and yet we touched into areas that were so vastly different... in the end, we covered great ground far better than any one speaker would care to attempt on a stage like this!"

Both doctors admitted that the AIUM presentation was a pilot for a much larger educational summit between them and other future speakers. Dr. Bard and his program director Dr. Lennard Gettz is underway mapping more duo-speakerships in 2025 including webinars and podcasts - pursuing that discussion-style energy that he first experienced at the AIUM conference with Dr. Ramos.




Cutaneous Lymphoma Presentation (Columbia U)

 

Saturday, April 5, 2025

GIVING BACK TO THOSE WHO GAVE ALL: SUPPORTING HUNTERSEVEN

April 3, 2025 – Dr. Robert Bard, a U.S. Air Force veteran and renowned cancer diagnostic imaging specialist—widely known as The Cancer Detective—recently met with the leadership team of the HunterSeven Foundation, a national advocacy organization dedicated to cancer awareness, research and resource support for military veterans and active service members. The foundation provides free, confidential cancer screenings to veterans and their families, prioritizing both their health and privacy.

HunterSeven Foundation supports individuals affected by military-related exposures by offering access to essential care and medical resources through a network of strategic partnerships and foundation-backed initiatives.

Dr. Bard has long committed his efforts to serving service personnel and first responders. His work includes a vast array of innovative diagnostic services as well as forming collaborations with advocacy groups like HunterSeven. He is also deeply involved in educational programs focused on prevention, early detection, and clinical research.

This recent meeting explored a potential alliance aimed at expanding cancer diagnostics for those exposed during service and often underdiagnosed.  The discussion also included plans for future educational presentations and outreach efforts, designed to bring awareness and access to health resources that many former service members may not currently have.

"So many from our veterans are (now) fighting a second battle once they come home", says Dr. Bard about post-service injuries. "Since the 70's, I have watched the pattern of disorders arise. I am committed to research and direct patient care for those who served our country and community... suffering from occupational exposures. Without a doubt- these jobs are dangerous. I'm happy to offer integrative arsenal of technologies and modalities that may not be available to them!"


Leading with Purpose at the HunterSeven Foundation


Timothy "Chachi" Pachasa
, the newly appointed Executive Director of the HunterSeven Foundation, brings with him a legacy of leadership, service, and unwavering commitment to the veteran community. A proud retiree of the United States Air Force, Tim dedicated nearly 25 years to military service—much of it spent shoulder-to-shoulder with U.S. Army units on the front lines.

As a Tactical Air Control Party (TACP) member and certified Joint Terminal Attack Controller (JTAC), Tim was one of the elite professionals responsible for coordinating and calling in airstrikes in combat zones, directly supporting soldiers in high-stakes environments. His career embodies a rare dual pride: deep-rooted in the Air Force, yet forged through years of battlefield collaboration with the Army.

Rising through the ranks to retire as a Command Chief Master Sergeant in 2019, Tim served at the highest levels of leadership within the Air Force. His post-retirement journey has been driven by one core mission: giving back. From various roles dedicated to supporting veterans, his path has now led him to the helm of the HunterSeven Foundation—a role he describes as “absolutely amazing.”

In his leadership at HunterSeven, Tim continues to channel his operational experience and deep sense of duty into advocacy and action, championing the health, well-being, and long-term care of post-9/11 veterans.


A MISSION TO GIVE BACK AND CARE FOR ITS OWN
By: Timothy "Chachi" Pachasa

I'm the Executive Director of the HunterSeven Foundation. I’m a proud military retiree with 25 years of service in the United States Air Force, though I also served closely with the U.S. Army as a Tactical Air Control Party (TACP) member and certified Joint Terminal Attack Controller (JTAC)—one of the guys calling in airstrikes on the front lines in support of Army units.

I’m proud to have worn the Air Force uniform and equally proud to have spent the majority of my career embedded with soldiers. I retired in 2019 as a Command Chief Master Sergeant, honored to have served at some of the highest levels of the Air Force. Since retirement, I’ve focused on giving back to the veteran community. Becoming Executive Director of the HunterSeven Foundation—an organization founded just months before I retired—has been an incredible opportunity to do exactly that: help veterans in their fight against cancer.


BATTLING CANCER BEYOND THE FRONT LINES
When people join the military, they accept the inherent risks—combat, training accidents, and more. But what’s harder to anticipate is the long-term exposure to environmental hazards that can dramatically increase the risk of cancer. Unfortunately, current cancer research doesn't always account for the extreme, unique exposures experienced during military service.

We’re seeing veterans being diagnosed with cancer at younger ages and in unexpected ways—patterns that simply don’t align with civilian exposure models. That’s why our work at HunterSeven is so important—blending military knowledge with cutting-edge medical research to better understand, detect, and prevent these cancers.


OUR MISSION & OBJECTIVES
HunterSeven was founded in 2018 as a nonprofit dedicated to supporting veterans affected by cancer. Our leadership includes a board of directors, a medical advisory board—which we’re proud to soon welcome Dr. Bard to—and a team of passionate brand ambassadors who share our mission across the country.  Our work centers around what I call the “Four Ts”:

Teach – We educate veterans about their exposure risks and how that could lead to cancer. We also train medical professionals to recognize and properly triage these unique cases and publish our findings to inform the broader medical community.

Test – Through bloodwork and MRIs, we focus on early detection—because we know it saves lives.

Treat – When veterans lack sufficient medical coverage, we raise funds to cover treatments or offset costs. Every dollar can mean a step closer to life-saving care.

Triumph – Whether it's a full recovery, improving a veteran’s quality of life, or supporting their family through difficult times, we celebrate every victory and ensure every sacrifice is honored and remembered.


A CALL TO ACTION

If you’re a veteran, know a veteran, or simply appreciate their service, we invite you to be part of this mission. Visit www.hunterseven.org to learn how you can help—whether by donating, volunteering, inviting us to your event, or supporting our medical screenings.


If you’re a medical professional, we welcome your time and expertise. If you're part of an organization that wants to collaborate, reach out—we’re always looking to grow our impact. And if you simply want to give—whether it’s 5 cents or $5,000—every bit helps.

Together, we can save veteran lives and fight cancer with the same intensity that these heroes showed while serving our country. We’re also proud to collaborate with amazing partners like the Integrative Cancer Research Society and Dr. Bard. These partnerships allow us to combine military insight with cutting-edge civilian medical innovation. We believe the future is bright, and we’re honored to be part of this shared mission.

Please stay tuned—there’s more to come.


Wednesday, March 26, 2025

ADVANCING SKIN DIAGNOSTICS: HIGH-RESOLUTION IMAGING FOR PRECISION AND NON-INVASIVE CARE

 By: Robert L. Bard, MD
Additional contributors: Roberta Kline, MD, Graciella Davi and Lennard Goetze, Ed.D 

Skin cancer diagnosis has long relied on visual examination and histopathological analysis via biopsy, a method that, while definitive, is often invasive, costly, and prone to unnecessary procedures. Current dermatologic standards incorporate dermoscopy as a primary tool for non-invasive assessment, improving diagnostic accuracy by allowing clinicians to visualize subsurface skin structures. However, despite its widespread adoption, dermoscopy remains limited in its ability to assess deeper tissue structures and vascular characteristics.

With advancements in high-resolution ultrasound and optical microscopy, dermatologic imaging is entering a new era. These technologies enable real-time, non-invasive evaluation of skin lesions, offering a functional perspective that extends beyond morphology to include vascular dynamics and tissue perfusion. Studies have demonstrated that high-frequency ultrasound can accurately measure tumor depth and differentiate benign from malignant lesions based on blood flow patterns and structural characteristics. Optical microscopy, in parallel, provides near-cellular resolution, enhancing diagnostic precision without the need for tissue extraction.


Quantifiable Data Capture in Visual Detection
The ability to distinguish benign from malignant skin lesions is particularly crucial in the case of moles, as only one in 33,000 suspicious lesions biopsied ultimately turns out to be melanoma. Advancements in non-invasive imaging modalities provide a means to monitor these lesions without unnecessary biopsies, which can cause scarring or persistent irritation.

Melanoma has long been studied using bio-microscopy, revealing key vascular characteristics that correlate with malignancy. Cancerous lesions exhibit distinct blood flow patterns—low blood flow often indicates less aggressive tumors, whereas high blood flow suggests a highly aggressive and potentially metastatic disease. High-resolution ultrasound not only measures tumor depth but also provides critical information regarding metastatic potential, enabling more informed clinical decision-making.

With the advent of high-resolution ultrasound and microvascular imaging, we can now achieve a level of detail approaching that of microscopy. This allows for the functional assessment of skin tissues, deeper structures like the thyroid and retina, and the detection of abnormal circulatory states, including distinguishing between inflammatory and cancerous blood vessels.

Additionally, microscopy enables visualization of capillary flow in the skin, including the movement of red blood cells and microscopic mites residing in hair follicles. These mites, while often unnoticed, play a role in cleansing dead tissue. From a physiological standpoint, an increased vascular supply in a lesion—whether due to cancer or an inflammatory condition like psoriasis—signals heightened disease activity. This provides a functional approach to not only assessing disease aggressiveness but also monitoring treatment response over time.

As a functional radiologist, my perspective on skin imaging extends beyond cellular morphology to vascular dynamics. My early investigations into optical skin imaging over a decade ago led to the discovery of microscopic movement within hair follicles—later identified as mites. These insights highlight the intricate and dynamic nature of the skin’s microenvironment.


Case Study: High-Resolution Ultrasound in the Early Detection of Melanoma
A 52-year-old male patient presented with a suspicious pigmented lesion on his forearm, initially identified during a routine dermatologic examination. Traditional dermoscopic evaluation revealed asymmetry and irregular vascular patterns, raising concern for possible melanoma. Rather than proceeding directly to biopsy, the clinician utilized high-resolution ultrasound with microvascular imaging to assess the lesion’s depth and vascular characteristics. The ultrasound revealed a well-defined lesion with increased vascular flow and a depth of 1.2 mm—features consistent with early-stage invasive melanoma.

Based on these findings, a targeted excisional biopsy was performed, confirming stage I melanoma. The use of high-resolution ultrasound allowed for precise measurement of tumor depth preoperatively, ensuring appropriate surgical margins and reducing unnecessary tissue removal. Furthermore, the patient benefited from a more streamlined diagnostic process, avoiding multiple biopsies and minimizing scarring. This case highlights the growing role of advanced imaging modalities in improving diagnostic accuracy, guiding clinical decisions, and reducing patient morbidity.

High-resolution ultrasound (HRUS) has proven to be a valuable tool in the preoperative assessment of cutaneous melanoma, enabling precise measurement of tumor thickness and aiding in surgical planning. A systematic review by Machet et al. (2009) demonstrated a strong correlation between HRUS measurements and histopathological findings, underscoring its reliability in evaluating melanoma depth .Madridge PublishersScienceDirect

Furthermore, research by Wortsman et al. (2013) highlighted the utility of HRUS in assessing locoregional metastases in melanoma patients. Their findings suggest that HRUS can significantly improve the early detection of metastatic spread, thereby facilitating timely and appropriate therapeutic interventions .ScienceDirect

These studies collectively support the integration of HRUS into the diagnostic workflow for melanoma, emphasizing its role in enhancing diagnostic accuracy and optimizing patient management strategies.


Vision for the Future
As imaging technology continues to evolve, we can anticipate a shift towards fully integrated, AI-assisted diagnostic platforms that combine multi-modal imaging techniques for enhanced accuracy and predictive analytics. The convergence of high-resolution ultrasound, optical coherence tomography, and advanced bio-microscopy will enable clinicians to diagnose and monitor skin conditions with unprecedented precision. In the near future, portable and point-of-care imaging devices may become standard practice, reducing reliance on biopsies while improving early detection rates and patient outcomes. By leveraging real-time imaging advancements, we are on the cusp of a new paradigm in dermatologic care—one that prioritizes precision, non-invasiveness, and enhanced patient monitoring.


Conclusion & Claim
Advancements in high-resolution ultrasound and optical microscopy have revolutionized the way we assess skin lesions, offering a non-invasive alternative to unnecessary biopsies. The ability to visualize vascular flow, tissue structure, and disease activity in real time enhances diagnostic precision and allows for continuous monitoring of treatment response. This shift parallels the historical impact of dermoscopy, which, since its development in the 1980s, has significantly improved melanoma detection by enabling the visualization of subsurface skin structures without the need for invasive procedures (Argenziano et al., 1998). Similarly, studies have demonstrated that high-frequency ultrasound can accurately assess tumor depth and vascular characteristics, aiding in the early detection and management of malignant skin lesions (Wortsman et al., 2013). Just as dermoscopy transformed early skin cancer diagnosis, modern high-resolution imaging is now redefining dermatologic and oncologic care.

Claim: High-resolution ultrasound and optical microscopy represent the next major evolution in skin diagnostics, providing a functional, non-invasive, and highly accurate alternative to traditional biopsy methods—ultimately improving patient outcomes and reducing unnecessary procedures.

References

1. Argenziano, G., Soyer, H. P., Chimenti, S., et al. (1998). "Dermoscopy: A Tutorial." Cancer, 85(1), 69-76.

2. Wortsman, X., Wortsman, J., Matsuoka, L. Y., et al. (2013). "High-resolution ultrasound applications in dermatology." Journal of the American Academy of Dermatology, 69(1), 105.e1-105.e11.


THYROID HEALTH: WHY ULTRASOUND MATTERS

3-25-2025   By: Dr. Leslie Valle-Montoya

Have you ever had your thyroid checked? If not, now is the time! While standard thyroid function tests measure hormone levels in the blood to detect disorders like hypothyroidism (underactive thyroid) and hyperthyroidism (overactive thyroid), they don’t tell the whole story. That’s where modern ultrasound technology steps in.

Unlike blood tests, which focus on hormone production, ultrasound provides a real-time, detailed view of the thyroid gland itself. This imaging technique uses sound waves to assess the gland’s size, shape, and structure—offering insights that hormone tests simply can’t provide.

Advanced ultrasound methods, such as 3D Doppler Blood Flow and Elastography, enhance diagnostic accuracy by measuring blood flow and tissue stiffness. These features help differentiate between benign and potentially malignant nodules, offering a clearer picture of thyroid health. By identifying whether nodules are solid or fluid-filled, ultrasound aids in assessing cancer risk and guiding further evaluation.

If you've never had a thyroid ultrasound, consider it an essential step in understanding your thyroid health beyond just hormone levels. A complete evaluation means looking at both function and structure—because when it comes to your health, knowledge is power.


Prologue:

LEARNING FROM THE ULTRASOUND GURU - (Day One)

Since COVID, I’ve connected with countless health professionals over Zoom. Even today, virtual meetings remain the norm for work engagements, often replacing in-person visits and hands-on collaborations.

But today, we broke that mold. I had the privilege of finally meeting Dr. Robert Bard in person—a true pioneer in diagnostic imaging! After five years of remote referrals, I traveled from Santa Barbara, CA, to New York City for a firsthand look at his cutting-edge arsenal of medical technology. More than just a tour, I also received an intensive crash course in ultrasound operation. Dr. Bard had previously mailed me a hospital-grade Terason T-3200 for my practice, and now, under his guidance, I was able to put it to use.

This marks the beginning of our TelemedScan remote overreading collaboration, and learning from "The Cancer Detective" himself was an incredible honor—an opportunity few get to experience from the front row.

"The best way to learn ultrasound is to be a patient," Dr. Bard explained. "Its real-time scanning ability lets you see as you scan—the screen tells all, right on the spot!"

With that in mind, we decided to scan my thyroid, a first for me. Given our collaboration on a perimenopause project, I knew it was time to practice what I’m about to preach. Having access to one of the best thyroid imaging experts in the field was an unexpected luxury—one I wasn’t about to pass up. During the session, I was introduced to the concept of sonology—where the radiologist directly controls the probe, eliminating the middle step of a technician. This hands-on approach allows for immediate interpretation, deeper exploration, and a more interactive learning experience between doctor and patient.


ABOUT THE AUTHOR

LESLIE VALLE-MONTOYA, MD is the Founder of Biomed Life and the Santa Barbara Longevity Center. After medical school, Dr. Valle focused on managing chronic disease starting with its links to poor nutrition and then introducing them into the world of energy frequencies.  She explores and includes non-invasive modalities such as: frequency therapies (including biofeedback), PEMF, proper detoxification, nutritional guidance and binaural beats as needed. - visit: www.biomedlifesb.com




The Essentials of Thyroid Imaging (part 2)

By: Dr. Robert Bard

When imaging detects a suspicious area, it can guide selective biopsies to obtain small tissue samples for further laboratory analysis (pathology). Combining imaging with pathology provides the most accurate information about the size, location, and aggressiveness of any issue detected.  In the case of thyroid imaging, use of an ultrasound uses sound waves to create images of the thyroid gland in the neck. It is often used for this organ because it is a non-invasive procedure that does not use ionizing radiation. It’s commonly used to evaluate lumps or nodules detected during a physical exam or other imaging tests and requires minimal preparation.

 Thyroid nodule (tumor) - doppler ultrasound

The ultrasound helps doctors visualize the thyroid's size, shape, and potential abnormalities like nodules, cysts, or inflammation, aiding in diagnosis and treatment planning. It’s typically performed when physical exams show:

 - A growth on the thyroid, known as a thyroid nodule (image - R).

- An enlarged or irregular thyroid (goiter).

- Abnormal lymph nodes near the thyroid.


THE ROLE OF THE THYROID GLAND: The thyroid is a butterfly-shaped organ in the endocrine system that regulates hormones influencing various bodily functions. These hormones affect both physical and mental performance, so unexplained symptoms may indicate a thyroid issue.

HYPERTHYROIDISM AND THYROID DISORDERS: Thyroid disorders can stem from various causes and affect the balance of hormones in the body. A range of treatments is available for managing thyroid issues, from medication to non-invasive procedures.




 


Part3:

THYROID CANCER:
Thyroid tumors are common but can be hard to diagnose by touch alone. Sonography is the primary method for detecting and monitoring suspicious nodules. Areas with calcium deposits are especially concerning and often require biopsy under ultrasound guidance. Parathyroid masses, which can cause significant health issues like bone loss in women or kidney stones in men, may also be detected. Ultrasound can also identify cancer spread to nearby lymph nodes, which can be biopsied with imaging guidance.


THYROID CANCER FAQ's

Q: Why is a sonogram important if I visit my doctor annually?
Blood tests often miss thyroid tumors, which can be difficult to detect through physical examination, especially if they are deep within the gland.

Q: What happens if a tumor is found?
Many benign conditions, like cysts, can be differentiated from cancer without a biopsy. Ultrasound can assess calcium content, which may indicate cancer, requiring further tests.

Q: Does every suspicious area require a biopsy?
Ultrasound screening and other tests can reduce unnecessary biopsies. Small suspicious areas are typically monitored for growth every 3-6 months before considering a biopsy.

Q: How far can thyroid cancer spread?
Most thyroid cancers grow slowly and spread locally. Metastasis is rare and can be evaluated using MRI scans.

Q: Can ultrasound detect parathyroid tumors that cause osteoporosis?
Parathyroid adenomas are typically benign but can lead to significant physical effects due to hormonal imbalances. These tumors can often be diagnosed with 3-D Power Doppler Histogram .

In summary, ultrasound imaging plays a crucial role in evaluating thyroid health by providing a safe, non-invasive, and highly detailed view of the gland. When combined with pathology, it enhances diagnostic accuracy, guiding appropriate treatment decisions. This synergy between imaging and laboratory analysis ensures a comprehensive approach to identifying and managing thyroid conditions effectively.


 

ABOUT THE AUTHOR-

ROBERT L. BARD, MD, PC, DABR, FASLMS - Advanced Imaging & Diagnostic Specialist

Having paved the way for the study of various cancers both clinically and academically, Dr. Robert Bard co-founded the 9/11 CancerScan program to bring additional diagnostic support to all first responders from Ground Zero. His main practice in midtown, NYC (Bard Diagnostic Imaging- www.CancerScan.com) uses the latest in digital Imaging technology has been also used to help guide biopsies and in many cases, even replicate much of the same reports of a clinical invasive biopsy. Imaging solutions such as high-powered Sonograms, Spectral Doppler, sonofluoroscopy, 3D/4D Image Reconstruction and the Spectral Doppler are safe, noninvasive, and does not use ionizing radiation. It is used as a complement to find anomalies and help diagnose the causes of pain, swelling and infection in the body’s internal organs while allowing the diagnostician the ability to zoom and ‘travel’ deep into the body for maximum exploration.


AIUM 2025: POCUS EDUCATIONAL POWER-DUO TAKES ON GLOBAL IMAGING & DIVERSITY

Dr. Ramos has been a global champion for Point of Care Ultrasound adoption across the continuum of care with a particular emphasis in primar...